Drug General Information
Drug ID
D0R1GV
Former ID
DCL001180
Drug Name
DPX-Survivac
Drug Type
Vaccine
Indication Ovarian cancer [ICD9: 183; ICD10:C56] Phase 1/2 [551020]
Company
Immunovaccine
Target and Pathway
Target(s) Baculoviral IAP repeat-containing protein 5 Target Info [551020]
KEGG Pathway Hippo signaling pathway
Hepatitis B
Pathways in cancer
Colorectal cancer
NetPath Pathway TCR Signaling Pathway
PANTHER Pathway Angiogenesis
Pathway Interaction Database Aurora B signaling
Validated targets of C-MYC transcriptional activation
FOXM1 transcription factor network
Aurora A signaling
Reactome Separation of Sister Chromatids
Resolution of Sister Chromatid Cohesion
RHO GTPases Activate Formins
Mitotic Prometaphase
WikiPathways IL-4 Signaling Pathway
Apoptosis-related network due to altered Notch3 in ovarian cancer
Mitotic Metaphase and Anaphase
Mitotic Prometaphase
Apoptosis
Interleukin-11 Signaling Pathway
Apoptosis Modulation and Signaling
References
Ref 5510202011 Pipeline of Immunovaccine.
Ref 5510202011 Pipeline of Immunovaccine.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.